Table 3:

Association between quality indicators of drug use and clinical outcomes adjusted for age, sex and time-varying comorbidities

IndicatorAll-cause admission to hospital
n = 162 264
Fracture-specific admission to hospital
n = 8 220
Death
n = 24 740
No. of patientsOR (95% CI)p valueNo. of patientsOR (95% CI)p valueNo. of patientsOR (95% CI)p value
Polypharmacy, no. of drugs
1–442 2561.002 8771.004 4631.00
5–964 9021.34 (1.32–1.36)< 0.0013 3061.18 (1.12–1.24)< 0.0015 3170.97 (0.93–1.01)0.1
≥ 1027 6121.98 (1.94–2.03)< 0.0011 0561.54 (1.42–1.66)< 0.0011 1310.59 (0.56–0.64)< 0.001
Use of PIMs
No71 9461.003 9101.0017 9871.00
Yes90 3181.27 (1.25–1.28)< 0.0014 9101.55 (1.48–1.62)< 0.0016 7530.39 (0.38–0.40)< 0.001
ARS score
0122 3021.006 9041.0021 6031.00
1–227 1231.46 (1.43–1.49)< 0.0011 2501.39 (1.31–1.48)< 0.0012 3500.75 (0.72–0.79)< 0.001
≥ 312 8391.32 (1.28–1.35)< 0.0016661.53 (1.41–1.66)< 0.0017870.49 (0.45–0.53)< 0.001
  • Note: ARS = anticholinergic risk scale, CI = confidence interval, PIM = potentially inappropriate medication.